Cinchocaine


Full Generic Medicine Info
Dosage/Direction for Use

Topical/Cutaneous
Surface anaesthesia
Adult: Up to 1% in cream and ointment.

Topical/Cutaneous
Haemorrhoids
Adult: As 0.05% w/w ointment (in combination with hydrocortisone): Apply onto the affected area in the morning and evening and after each stool. As suppository containing 5 mg/unit (in combination with hydrocortisone): Insert 1 suppository in the morning and evening and after each stool.
Contraindications
Complete heart block; pyogenic infection at or near the skin. Application to inflamed or infected tissues or to damaged skin mucosa; instillation into the middle ear.
Special Precautions
Elderly; debilitated patients; child; epilepsy; impaired cardiac conduction or respiratory function; shock; hepatic impairment; myasthenia gravis. Do not to rub or touch the eye while anaesthesia persists. Avoid application for prolonged periods and to extensive areas. Pregnancy, lactation.
Adverse Reactions
Restlessness; excitement; nervousness; paraesthesias; dizziness; tinnitus; blurred vision; nausea; vomiting; muscle twitching; tremors; convulsions; hypotension; bradycardia; arrhythmias; cardiac arrest.
Action
Cinchocaine prevents or diminishes nerve impulse conduction near to the site of admin. It also has membrane-stabilising effect owing to decrease of permeability of the nerve cell to sodium ions.
Onset: Up to 15 minutes.
Duration: 2-4 hr.
Storage
Topical/Cutaneous: Store below 25°C.
CIMS Class
Anaesthetics- local & general
ATC Classification
S01HA06 - cinchocaine ; Belongs to the class of local ophthalmologic anesthetics.
N01BB06 - cinchocaine ; Belongs to the class of amides. Used as local anesthetics.
S02DA04 - cinchocaine ; Belongs to the class of analgesic and anesthetic agents used as otologicals.
D04AB02 - cinchocaine ; Belongs to the class of topical anesthetics used in the treatment of pruritus.
C05AD04 - cinchocaine ; Belongs to the class of local anesthetics. Used in the topical treatment of hemorrhoids and anal fissures.
Disclaimer: This information is independently developed by CIMS based on cinchocaine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in